Publicaciones

 

  • Pastor F, Soldevilla MM, Villanueva H, Kolonias D, Inoges S, de Cerio AL, Kandzia R, Klimyuk V, Gleba Y, Gilboa E, Bendandi M. CD28 aptamers as powerful immune response modulators. Mol Ther Nucleic Acids. 2013 Jun 11;2:e98. IF: 7.041
    ABSTRACT CORTESÍA DE PUBMED

  • de Cerio AL, Inogés S, Ai WZ, Villanueva H, Pastor F, Soldevilla MM, Soria E, Bendandi M. Successful idiotypic vaccination following stem cell allotransplant in lymphoma. Leuk Lymphoma. 2013 Apr;54(4):881-4. IF: 2.397.
    ABSTRACT CORTESÍA DE PUBMED
     
  • Guarnieri A, Moreno-Montañés J, Alfonso-Bartolozzi B, Sabater AL, García-Guzmán M, Andreu EJ, Prosper F. Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy. Int J Ophthalmol. 2014 Dec 18;7(6):988-95. 
    ABSTRACT CORTESÍA DE PUBMED
     

  • Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, Gabilondo I, Martínez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fernández B, Bullich S, Sánchez-Dalmau B, Graus F, Villoslada P, Saiz A. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One. 2014 Dec 1;9(12):e113936. 
    ABSTRACT CORTESÍA DE PUBMED
     

  • Sánchez-Guijo F, Caballero-Velázquez T, López-Villar O, Redondo A, Parody R, Martínez C, Olavarría E, Andreu E, Prósper F, Díez-Campelo M, Regidor C, Villaron E, López-Corral L, Caballero D, Cañizo MC, Pérez-Simon JA.  Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2014, 20(10):1580-5.
    ABSTRACT CORTESÍA DE PUBMED

  • Inoges S, de Cerio AL, Villanueva H, Pastor F, Bendandi M. Idiotype vaccine production using hybridoma technology. Methods Mol Biol. 2014;1139:367-87.
    ABSTRACT CORTESÍA DE PUBMED

  • Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj JI, Larrea E, Pereboev A, Lasarte JJ, Rodríguez-Lago I, Iñarrairaegui M, Sangro B, Prieto J, Sarobe P. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular therapy. Methods & clinical development 03/2015; 2:15006. 
    ABSTRACT CORTESÍA DE PUBMED
     

  • Redondo P, Gímenez de Azcarate A, Núñez-Córdoba JM, Andreu EJ, García-Guzman M, Aguado L, Prosper F. Efficacy of Autologous Melanocyte Transplantation on Amniotic Membrane in Patients With Stable Leukoderma: A Randomized Clinical Trial. JAMA Dermatol. 2015 Apr 22. doi: 10.1001/jamadermatol.2015.0299. [Epub ahead of print]
    ABSTRACT CORTESÍA DE PUBMED
     

  • Tusé D, Ku N, Bendandi M, Becerra Carlos, Collins RH, Langford N, Inogés Sancho S, De Cerio ALD, Pastor F, Kandzia R, Thieme F, Jarczowski F, Krause D, Ma J.K.-C., Pandya S, Klimyuk V, Gleba Y, Butler-Ransohoff JE. Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma. Aceptado para su pulicacion en: BioMed Research International

  • Aranda P, Agirre X, Ballestar E, Andreu EJ, Román-Gómez J, Prieto I, Martín-Subero JI, Cigudosa JC, Siebert R, Esteller M, Prosper FEpigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One. 4(11):e7809 (2009)
    ABSTRACT CORTESÍA DE PUBMED

  • Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, Fröde R, Inogés S, Lòpez-Dìaz de Cerio A, Soria E, Villanueva H, Vancanneyt G, McCormick A, Tusé D, Lenz J, Butler-Ransohoff JE, Klimyuk V, Gleba YRapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol. 2010 Dec;21(12):2420-7
    ABSTRACT CORTESÍA DE PUBMED

  • Perez Simon JA, Lopez-Villar O, Andreu EJ, Rifon J, Muntion S, Diez-Campelo M, Sanchez Guijo FM, Marti- nez C, Lopez D, Del Canizo C. Mesenchymal stem cells expanded in vitro with human serum for the treat- ment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 96(7):1072-6. (2011)
    ABSTRACT CORTESÍA DE PUBMED

  • Mario M. Soldevilla, Susana Inogés, Ascensión López-Díaz de Cerio, Fernando Pastor, Helena Villanueva and Maurizio BendandiBiological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorec- tal Cancer. Journal of Cancer Research Updates. 2012; 1: 122-128.
    ABSTRACT CORTESÍA DE PUBMED

  • R Diez Valle, A Lopez-Diaz de Cerio, S Inogés, S Tejada, F Pastor, H Villanueva, J Gallego, J Espinos, J Aris- tu, MA Idoate, E Andreu, M BendandiDendritic cell vaccination in glioblastoma after fluorescence-guided resection. World J Clin Oncol 2012; 3:142-149
    ABSTRACT CORTESÍA DE PUBMED



"Aplicamos los avances científicos a nuevos tratamientos de terapia celular, tisular y génica, para realizar ensayos clínicos y ofrecer al paciente nuevas vías terapéuticas", Dr. Enrique Andreu, investigador principal-

Más información:

Contactar

Contacto:
Marisol Ripa
Avda. Pío XII, 55
31008 Pamplona
España

(+34) 948 194 700 Ext. 1010
msripa@unav.es